260 related articles for article (PubMed ID: 34588497)
21. Identification of Prognostic RBPs in Osteosarcoma.
Li B; Fang L; Wang B; Yang Z; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
[TBL] [Abstract][Full Text] [Related]
22. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Liu W; Xie X; Qi Y; Wu J
JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
[TBL] [Abstract][Full Text] [Related]
24. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
Zhang N; Han Y; Cao H; Wang Q
J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
[TBL] [Abstract][Full Text] [Related]
25. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
27. TYRO protein tyrosine kinase-binding protein predicts favorable overall survival in osteosarcoma and correlates with antitumor immunity.
Xu HR; Chen JJ; Shen JM; Ding WH; Chen J
Medicine (Baltimore); 2022 Sep; 101(39):e30878. PubMed ID: 36181123
[TBL] [Abstract][Full Text] [Related]
28. Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes.
Yahiro K; Matsumoto Y; Yamada H; Endo M; Setsu N; Fujiwara T; Nakagawa M; Kimura A; Shimada E; Okada S; Oda Y; Nakashima Y
Cancer Immunol Immunother; 2020 May; 69(5):745-758. PubMed ID: 32047957
[TBL] [Abstract][Full Text] [Related]
29. ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Comb Chem High Throughput Screen; 2023; 26(1):135-148. PubMed ID: 35388751
[TBL] [Abstract][Full Text] [Related]
30. PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma.
Chen Q; Xing C; Zhang Q; Du Z; Kong J; Qian Z
Sci Rep; 2024 Jun; 14(1):13790. PubMed ID: 38877061
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma.
Wen J; Wan L; Chen W; Dong X
J Orthop Surg Res; 2024 Jun; 19(1):356. PubMed ID: 38879525
[TBL] [Abstract][Full Text] [Related]
33. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
Wang L; Lin Y; Yuan Y; Liu F; Sun K
Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
[TBL] [Abstract][Full Text] [Related]
34. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
[TBL] [Abstract][Full Text] [Related]
35. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.
Liu Y; Guan J; Chen X
Pathol Oncol Res; 2019 Jul; 25(3):1091-1102. PubMed ID: 30411296
[TBL] [Abstract][Full Text] [Related]
36. Revealing the link between macrophage in microenvironment of osteosarcoma and poor prognosis by utilizing the Integrated analysis.
Zheng S; Peng J; Jia J; Wu T; Cheng X
J Musculoskelet Neuronal Interact; 2021 Mar; 21(1):130-137. PubMed ID: 33657763
[TBL] [Abstract][Full Text] [Related]
37. LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4.
Yang D; Liu K; Fan L; Liang W; Xu T; Jiang W; Lu H; Jiang J; Wang C; Li G; Zhang X
Cancer Lett; 2020 Mar; 473():33-49. PubMed ID: 31904478
[TBL] [Abstract][Full Text] [Related]
38. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
39. The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy.
Wang Z; Wu H; Chen Y; Chen H; Yuan W; Wang X
J Oncol; 2021; 2021():4836292. PubMed ID: 34335756
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients.
Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z
Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
